Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L7 pseudogene 3 (RPL7P3) is a processed pseudogene in the human genome that resembles the functional ribosomal protein L7 gene (RPL7) but does not produce a functional protein. Pseudogenes are DNA sequences similar to normal genes but typically non-functional due to mutations or lack of regulatory elements such as promoters and introns[2][5]. There are thousands of such ribosomal protein pseudogenes scattered across the human genome, many arising by retrotransposition. These sequences are not transcribed to functional RNAs or translated into functional proteins and therefore do not serve as drug targets or have clear biological functions or disease roles[2][5][8]. Key points: - RPL7P3 does not encode a functional protein. - It is not a receptor, enzyme, transporter, or any recognized molecular target. - It is not considered a therapeutic target in current biomedical literature. - No functions, drug interactions, biomarker roles, or safety issues are attributed to this pseudogene[2][5][8]. For structured information needs such as drug interactions or disease roles, only the functional gene (RPL7) is relevant, not its pseudogenes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L7 pseudogene 3 (RPL7P3).